论文信息 - Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK. - 字舞流文

Cost-effectiveness of pembrolizumab for previously treated MSI-H/dMMR solid tumours in the UK.

M. Amonkar | Jan Mikelson | M. Madin-Warburton | R. Aguiar-Ibáñez | G. McCarthy | R. Xu | Kate Young | T. Mantaian | Elizabeth Brook | Kaylie Metcalfe | Carl Seyla-Hammer